HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stada Makes US Consumer Health Play After Strong Gains In Europe

Executive Summary

Stada has entered the US dietary supplements category following significant gains for its Branded Products business in 2020. Acquisitions helped to drive up Branded Products sales by 27% last year, enabling Stada to become a top-five player in Europe's consumer health market. 

You may also be interested in...

‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere

Stada Arzneimittel is looking for local partners and/or acquisition opportunities in the US to expand its offer and quickly establish its presence in the country, Stada executive vice president Roger Scarlett-Smith tells HBW Insight in this exclusive interview.

Stada’s Goldschmidt Looks To Take Consumer Health Global

Stada CEO Peter Goldschmidt tells HBW Insight about his ambition to enter the US consumer health market as part of a push to take the business global. 

Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits

Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level. 

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts